HPR87 A Review and Analysis of Medicines Following the Innovative Licensing and Access Pathway (ILAP) in the UK: Does the Pathway Lead to Faster Regulatory Approval and HTA Recommendation?
| Autor: | Elsakary, Y, Connelly, B, Scrutton, H, Finocchiaro, D, Heathfield, A, Bending, MW |
|---|---|
| Zdroj: | In Value in Health December 2022 25(12) Supplement:S248-S248 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect